Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-046424

Chief Business Officer sold 18,000 shares at $9.25 ($166,500)

  • Chief Business Officer acquired 18,000 shares (option exercise)
  • Chief Business Officer gave up 3,603 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Virani Shafique · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-15 Shares withheld for taxes : show line 1 in the form 10b5-1 −3,603 $9.19 $33,112 140,351 D
2023-08-15 Exercise or conversion : show line 2 in the form 10b5-1 +18,000 $2.22 $39,960 158,351 D
2023-08-15 Sale : show line 3 in the form 10b5-1 −18,000 $9.25 $166,500 140,351 D
Open-market sales · 18,000 sh · avg $9.25 · $166,500

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-08-15 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −18,000 $2.22 2030-03-03 18,000 451,469 D
Loading xslF345X05/doc4.xml…